23/11/2021
Severine Duband, our Marketing Director was interviewed by the journalist of the 'Pharmaceutical Post', to talk about Symbioze and how we developed the product. The main challenge for manufacturers is...
Continue Reading
30/09/2021
TACKLING HIGH-VOLUME ADMINISTRATION CHALLENGES WITH A SMART, SUSTAINABLE ON-BODY INJECTOR PLATFORM In this article, Séverine Duband, Marketing Director, Drug Delivery Devices at Nemera, introduces Symbioze, Nemera’s novel on-body ...
Continue Reading
02/09/2021
Between-Batch Bioequivalence (BBE): An Alternative Statistical Method to Assess In Vitro Bioequivalence of Nasal Product INTRODUCTION In the pharmaceutical industry, we can see the development of generics is significantly growing....
Continue Reading
05/06/2021
A new statistical method to assess in vitro bioequivalence of nasal products Bioequivalence testing is an essential step during the development of ...
Continue Reading
05/06/2021
Nemera is developing and manufacturing complex nasal drug delivery solutions.
Continue Reading
05/06/2021
Nemera - an integrated CDMO and Own-IP player In this report, Alira Health in partnership with MassMEDIC analyzes the rapidly evolving DDD ...
Continue Reading